By Ayai Tomisawa TOKYO (Reuters) - Japan's Fujifilm Holdings Corp said it was difficult to estimate the profitability of its influenza drug Avigan, which has been earmarked to fight Ebola, given the uncertainty over the spread of virus, a company executive said on Thursday. Fujifilm has said it is expanding the production Avigan anti-influenza. France and Guinea plan to conduct clinical trials of Avigan 200 mg tablets, made by Fujifilm group company Toyama Chemical Co, in Guinea to treat Ebola in mid-November. ...
via Health News Headlines - Yahoo News http://ift.tt/1rVaiNt
No comments:
Post a Comment